Bloomberg Businessweek US - May 18, 2020

この問題で

Remdesivir at the Ready
Gilead took a series of crucial steps to prepare its antiviral drug for this moment.

Tilting at Covid Conspiracies
A tiny U.S. agency tries to battle falsehoods from Russia, China—and Trump.

Colleges vs. the Covid-19 Gap Year

As more affluent kids defer, school budgets will suffer if scholarship recipients replace them

6 mins

Escape From the Valley

Working from home, young techies realize it’s cheaper to live outside the Bay Area

3 mins

The Trader Who Fell To Earth

A new book reveals fresh details about the man blamed for helping cause the 2010 Flash Crash that erased $1 trillion of value in minutes

9 mins

The Next Housing Crisis Is Here

Bans on evictions and rent strikes could trigger a wave of mortgage defaults by landlords

6 mins

The Sticky Politics Of Cheap Oil

The collapse in oil prices and Texas’ pain could reshape the electoral map in November

7 mins

“This is a time when people need trusted brands”

In an interview with Bloomberg Businessweek’s Carol Massar, the good-business champion behind consumer brands from Dove to Ben & Jerry’s shares how the pandemic is strengthening his resolve

5 mins

All Eyes On Gilead

Emergency approval of the antiviral drug remdesivir is the first good news of this pandemic. Gilead Sciences was ready

10+ mins

UFC's $5 billion fight

UFC has become the first major sport back during the pandemic, while defending itself against a groundbreaking antitrust suit that alleges it abused its market power to hold down fighters’ share of its revenue

10+ mins

The U.S. Department Of Conspiracy Theory Preparedness

Deep inside the Deep State, a tiny agency is working to stop Covid-19 disinformation. Under Trump, it hasn’t stood a chance

10 mins

Fore's a Crowd

Social distancing has always been part of golf, but the pandemic is pushing clubs to extremes.

4 mins

Bloomberg Businessweek US の記事をすべて読む

Bloomberg Businessweek US Magazine Description:

Bloomberg Businessweek delivers the business information you need: surprising and timely perspectives on the most important issues of today and unique stories you won’t find anywhere else. With Bloomberg Businessweek you'll have the insights you need to take advantage of the new reality and thrive in today's complex global economy.